Back to search

Peptide record

TPDB21257

Antibacterial Anticancer Antiviral Toxicity modified_plain modified
31 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB21257
Antibacterial Anticancer Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
modified_plain
Yes
A 31-aa modified multi-activity (Antibacterial, Anticancer, Antiviral, and other sources) peptide sequence curated from Peptipedia, with an available 3D structural model.
Modified, details unspecified
Sequence
IGIEDLSKNIKDKIDKIIHDFVDKTLPDQGX
Physicochemical Analysis
C152H251N39O49
ARCMWY
DI
3408.90
4.69
6
7
10
-2
13.01
-0.532
110.00
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
0
0.00
4
Residue Composition
number
0
A
0
R
1
N
6
D
0
C
1
E
1
Q
2
G
1
H
6
I
2
L
5
K
0
M
1
F
1
P
1
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 1 D: 6 C: 0 E: 1 Q: 1 G: 2 H: 1 I: 6 L: 2 K: 5 M: 0 F: 1 P: 1 S: 1 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
31
C152H251N39O49
3408.90
4.69
-2
13.01
-0.532
Evidence Records 1 records
Evidence 1 Activity

Activity

50% Cytotoxicity
Toxicity
>=25 µM
Cytotoxic
50% Cytotoxicity | >=25 | µM | target cell: Human embryonic kidney HEK293T cells

Target

Human embryonic kidney HEK293T cells

Source & Reference

NA
DBAASP
Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo. | Antiviral Res | 2019